Physician profile
Kari K Mathison
NPI 1124124276
$2,073.14
in general payments reported to CMS, 2019-2025
18 companies · $73.89 in 2025
The $73.89 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,239 · 2020: $492 · 2021: $183 · 2022: $84.83 · 2025: $73.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $73.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $73.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $737.90 | 2019-2025 | Wainua |
| Novo Nordisk INC | $256.17 | 2019-2020 | |
| Glaxosmithkline, LLC. | $183.71 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $173.05 | 2019-2020 | |
| Dexcom, INC. | $125.15 | 2019 | |
| Pfizer INC. | $119.14 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $89.51 | 2019-2020 | |
| Abbvie INC. | $70.93 | 2021-2025 | |
| Allergan, INC. | $65.11 | 2019-2020 | |
| Lilly USA, LLC | $39.57 | 2019 | |
| Amarin Pharma, INC. | $37.39 | 2019-2020 | |
| Sanofi Pasteur INC. | $37.11 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $34.94 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.57 | 2019 | |
| Amgen INC. | $23.02 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $20.57 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.41 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Mathison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.